The state of the United States is a major factor in the plans of leaders from many industries that require cleanrooms. With large presences and footprints from pharmaceutical giants like Pfizer and Johnson & Johnson, as well as hi-tech manufacturing powerhouses like Intel and Nvidia.
What affects the US market will intrinsically affect these sectors. With a new President in the country, there will be huge changes to come that will impact these industries, and therefore their cleanroom construction partners.
Using tariffs has been a big point of discussion with the new Trump administration, with the new President promising sectoral tariffs “starting at” 25% for pharmaceuticals and semiconductor chip imports.
Tariffs are a charge on top of the existing cost for imported products, with the US-based entity paying an increased rate to import the product. The reason for a tariff can be varied, but one of the main ideas is often to promote domestic manufacturing.
Cleanroom facilities take varying lengths of time to build, with semiconductor chip fabs taking many years
Domestic manufacturing in the US is a big target of these tariffs. Pfizer itself has ten manufacturing sites and two distribution centres located in nine different states, whilst Intel has around ten, further investing billions of dollars due to the CHIPS Act.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.
Subscribe now Already a subscriber? Sign in here.